Finnegan defeats U.S. enforcement campaign by non-practicing entity against BMW Group

Finnegan successfully represented BMW Group in a declaratory judgment action for noninfringement and invalidity of U.S. Patent No. 8,289,082 in the U.S. District Court for the District of Columbia, against Arigna Technology Ltd., an Irish patent monetization firm affiliated with Atlantic IP Services Ltd. This action was part of a long-fought battle between BMW Group and Arigna, spanning several years and multiple venues, including U.S. District Courts, the U.S. International Trade Commission, the Federal Circuit, and the U.S. Patent and Trademark Office.

The District of Columbia dismissed Arigna’s counterclaim of patent infringement with prejudice after Finnegan secured a royalty free covenant-not-to-sue on the asserted patent, resulting in a zero-dollar walkaway and ensuring Arigna could not reassert its claims against BMW Group. This outcome represented a definitive victory, bringing a close to U.S. litigation surrounding the ’082 patent—the last of four patents initially asserted by Arigna as part of its broader enforcement campaign.

Arigna’s assertion of the ’082 patent traces back to May 2021, when it sued BMW Group, along with other vehicle defendants, in the U.S. District Court for the Eastern District of Texas, followed by a corresponding complaint at the ITC, alleging discrete chips in BMW vehicles infringed the asserted patent. While the Texas case was stayed, Finnegan successfully defended BMW Group at the ITC, where the administrative law judge ruled in BMW’s favor, finding all asserted claims of the ’082 patent both invalid and non-infringed. Despite this decisive loss, Arigna sought to revive its claims in Texas, targeting BMW AG after BMW NA was dismissed for improper venue. In response, Finnegan filed the declaratory judgment action in the District of Columbia on behalf of BMW Group.

In addition to the district court litigation, Finnegan also pursued parallel actions before the USPTO, filing a petition for Inter Partes Review and an Ex Parte Reexamination to challenge the validity of the ’082 patent. These proceedings further undermined the patent’s validity and added another layer of pressure on Arigna, requiring Arigna to juggle litigations on multiple fronts.

Although the ITC’s findings of invalidity and noninfringement, combined with the ongoing Patent Office proceedings, played a key role in weakening Arigna’s infringement claims, the final blow came after Arigna became embroiled in a public dispute with its litigation funder, Longford Capital Fund III, LP. Finnegan had consistently pursued a rigorous discovery strategy aimed at uncovering details of Arigna’s funding arrangements, which Arigna had resisted as allegedly neither relevant nor discoverable. However, once the funding dispute became public, Finnegan seized the opportunity to turn up the pressure by subpoenaing Longford and filing a motion to intervene in the fee dispute between Arigna and Longford.

This pressure ultimately led to Arigna’s unilateral dismissal of the Texas case and the withdrawal of its counsel from the District of Columbia action. In the wake of Arigna’s internal challenges, it agreed to not sue BMW Group on the ’082 patent and to dismiss its infringement counterclaim with prejudice, bringing a final, favorable, and decisive resolution for BMW Group.

Despite Arigna's protracted litigation efforts across multiple venues, including the ITC, U.S. District Courts, and in Germany, Finnegan’s comprehensive legal strategy conclusively defended BMW Group against Arigna’s efforts to extract a settlement payment. This dismissal marked the definitive end to Arigna’s claims against BMW Group in the United States, demonstrating the effectiveness of Finnegan’s multi-faceted legal strategy.